Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

68 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Allogeneic hematopoietic stem cell transplant following chemotherapy containing l-asparaginase as a promising treatment for patients with relapsed or refractory extranodal natural killer/T cell lymphoma, nasal type.
Yokoyama H, Yamamoto J, Tohmiya Y, Yamada MF, Ohguchi H, Ohnishi Y, Okitsu Y, Fukuhara N, Ohba-Ohtsuka R, Kohata K, Ishizawa K, Kameoka J, Harigae H. Yokoyama H, et al. Among authors: ohguchi h. Leuk Lymphoma. 2010 Aug;51(8):1509-12. doi: 10.3109/10428194.2010.487958. Leuk Lymphoma. 2010. PMID: 20496989
Favorable outcome of unrelated cord blood transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia.
Onishi Y, Sasaki O, Ichikawa S, Inokura K, Katsuoka Y, Ohtsuka Ohba R, Okitsu Y, Kohata K, Ohguchi H, Fukuhara N, Yokoyama H, Yamada MF, Yamamoto J, Ishizawa K, Kameoka J, Harigae H. Onishi Y, et al. Among authors: ohguchi h. Biol Blood Marrow Transplant. 2011 Jul;17(7):1093-7. doi: 10.1016/j.bbmt.2011.01.010. Epub 2011 Jan 28. Biol Blood Marrow Transplant. 2011. PMID: 21277378 Free article.
Myeloablative cord blood transplantation for adults with hematological malignancies using tacrolimus and short-term methotrexate for graft-versus-host disease prophylaxis: single-institution analysis.
Yamada MF, Miyamura K, Fujiwara T, Kohata K, Okitsu Y, Ohguchi H, Yamamoto J, Yokoyama H, Tomiya Y, Ishizawa K, Kameoka J, Harigae H. Yamada MF, et al. Among authors: ohguchi h. Transplant Proc. 2008 Dec;40(10):3637-42. doi: 10.1016/j.transproceed.2008.06.102. Transplant Proc. 2008. PMID: 19100456
Novel antimyeloma therapeutic option with inhibition of the HDAC1-IRF4 axis and PIM kinase.
Harada T, Ohguchi H, Oda A, Nakao M, Teramachi J, Hiasa M, Sumitani R, Oura M, Sogabe K, Maruhashi T, Takahashi M, Fujii S, Nakamura S, Miki H, Kagawa K, Ozaki S, Sano S, Hideshima T, Abe M. Harada T, et al. Among authors: ohguchi h. Blood Adv. 2023 Mar 28;7(6):1019-1032. doi: 10.1182/bloodadvances.2022007155. Blood Adv. 2023. PMID: 36129197 Free PMC article.
[Case report; acquired factor V inhibitor with hemoptysis and hematuria].
Ohguchi H, Okitsu Y, Kobayashi M, Yokoyama H, Suzuki S, Ishikawa M, Oba R, Yamamoto J, Isizawa K, Harigae H. Ohguchi H, et al. Nihon Naika Gakkai Zasshi. 2011 Jan 10;100(1):182-4. doi: 10.2169/naika.100.182. Nihon Naika Gakkai Zasshi. 2011. PMID: 21387651 Japanese. No abstract available.
68 results